Search

Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo

FAILED CLINICAL TRIAL PUTS ELI LILLY CANCER DRUG IN LIMBO

An Eli Lilly drug on the market for a rare form of cancer is now in limbo, after it failed a trial needed to retain the FDA approval...

 
 
 

ROCHE R&D EXEC BEGINS A NEW VOYAGE WITH BIOTECH MOVE

Another day, another Big Pharma exec jumps ship to biotech: This morning, it's Omar Khwaja, M.D., Ph.D., who becomes chief medical...

 
 
 
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More

BIO ROUNDUP: 2019 TRIALS, PILGRIM PRICE CHAT, PRE-XMAS SALES & MORE

It's beginning to look a lot like, well, the last roundup of the year, with plenty of news to pack in before our holiday breather....

 
 
 
 
 
 
15 For '19: Key Clinical Data to Watch For Next Year

15 FOR '19: KEY CLINICAL DATA TO WATCH FOR NEXT YEAR

On Monday, Xconomy began our annual look ahead at clinical trials that could define biotech and have profound healthcare effects in...

15 For '19: Key Clinical Data To Watch For Next Year

15 FOR '19: KEY CLINICAL DATA TO WATCH FOR NEXT YEAR

It can take decades and billions of dollars to develop a drug, and its fate-and often that of its developer-rests in the outcome of...

 
 
 
FDA approves Celltrion, Teva's Rituxan biosimilar, but with a narrow label

FDA APPROVES CELLTRION, TEVA'S RITUXAN BIOSIMILAR, BUT WITH A NARROW LABEL

The agency approved Truxima for three lymphoma indications, whereas European regulators approved it last year for all the same indications...

 
 
 
Amazon Wants to Help Doctors and Patients Process Healthcare Data

AMAZON WANTS TO HELP DOCTORS AND PATIENTS PROCESS HEALTHCARE DATA

Amazon intends to wade deeper into healthcare. The company announced Tuesday that it is working with groups in the industry to help...

Amazon's latest healthcare foray is a major step into health informatics

AMAZON'S LATEST HEALTHCARE FORAY IS A MAJOR STEP INTO HEALTH INFORMATICS

A new software service from the company called Amazon Comprehend Medical uses machine learning and natural language processing to extract...

 
 
 
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

BIO ROUNDUP: PRICES ON TV, NOVARTIS HEARTS RADIO, WARP DRIVE'S END

Two new battlegrounds emerged this week in the nation's ongoing drug pricing debate. The first involved television: The federal government...

 
 
 
Warp Drive's Odyssey Ends with a Buyout-By Revolution, Not Sanofi

WARP DRIVE'S ODYSSEY ENDS WITH A BUYOUT-BY REVOLUTION, NOT SANOFI

Warp Drive Bio started up in 2012 with a potential buyer, Sanofi, already in place. Six years later the Cambridge, MA, company is being...

Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant's IPO & More

BIO ROUNDUP: NOBEL PRIZES, DUCHENNE STEPS, GUARDANT'S IPO & MORE

Cancer immunotherapy is all the rage these days. The idea of harnessing the immune system to treat cancer has sparked billions of dollars...

 
 
 
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom

FDA APPROVES ROCHE DRUG FOR ALL HEMOPHILIA A PATIENTS, BUT RIVALS LOOM

The treatment landscape for hemophilia is changing fast, and today marks a turning point. The FDA has just cleared Roche to sell its...